Drug Shortage Report for AURO-ZIPRASIDONE
Report ID | 210229 |
Drug Identification Number | 02449544 |
Brand name | AURO-ZIPRASIDONE |
Common or Proper name | AURO-ZIPRASIDONE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ZIPRASIDONE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 60's |
ATC code | N05AE |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-11-15 |
Estimated end date | 2024-02-15 |
Actual end date | 2024-02-13 |
Shortage status | Resolved |
Updated date | 2024-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-14 | English | Compare |
v7 | 2024-02-13 | French | Compare |
v6 | 2024-02-13 | English | Compare |
v5 | 2024-01-29 | French | Compare |
v4 | 2024-01-29 | English | Compare |
v3 | 2023-11-16 | English | Compare |
v2 | 2023-11-15 | French | Compare |
v1 | 2023-11-15 | English | Compare |
Showing 1 to 8 of 8